Cataract Surgery Stephen G. Slade MD, FACS

Post on 28-Jan-2016

24 views 0 download

description

Cataract Surgery Stephen G. Slade MD, FACS. Financial Disclosure. Alcon, AMO, B&L Consultant, Clarity, NuLens, RVO, Technolas. This presentation represents the speaker’s professional experience. US Cataract Market. 18,900,000 Global Procedures 2010 3,261,000 US Procedures - PowerPoint PPT Presentation

Transcript of Cataract Surgery Stephen G. Slade MD, FACS

1

Cataract SurgeryStephen G. Slade MD, FACS

2

Financial Disclosure

Alcon, AMO, B&L Consultant, Clarity, NuLens, RVO,

Technolas

2This presentation represents the speaker’s professional experience.

3

• 18,900,000 Global Procedures 201018,900,000 Global Procedures 2010

• 3,261,000 US Procedures3,261,000 US Procedures

• 900 million US Equipment and Packs900 million US Equipment and Packs

• 85 million US Presbyopes85 million US Presbyopes

• 72% with 0.5 D or greater Astigmatism72% with 0.5 D or greater Astigmatism

US Cataract MarketUS Cataract Market

Medicare, Marketscope

4

US Eye SurgeonsUS Eye Surgeons

Cataract Only Surgeons 4,990

Refractive Only 1,350

Cataract / Refractive Surgeons 2,260

Total 8,600

Marketscope Surveys

5

6

Is Cataract Surgery Effective Enough?Is Cataract Surgery Effective Enough?

20/40 or better

20/40 or better

20/20 or better

20/20 or better

20/40 and J3 or better

20/40 and J3 or better

20/25 and J1 or better

20/25 and J1 or better

75%75%

100%100%

85%85%

35%35%* Adapted from FDA clinical data for Crystalens and Wavelight Trials Wavelight FDA Trial, Myopia Astigmatism. Crystalens AT 45 FDA

* Adapted from FDA clinical data for Crystalens and Wavelight Trials Wavelight FDA Trial, Myopia Astigmatism. Crystalens AT 45 FDA

Only 6.4% penetration rate

Visual Outcomes less than LASIK

No safety improvement

Surgeon confidence lower

Only 6.4% penetration rate

Visual Outcomes less than LASIK

No safety improvement

Surgeon confidence lower

7

Medicare vs Private Pay

7

Source: 2007 Medicare Data

66% Medicare

22% Non Medicare

12% Medicare Managed Care

8

US Surgeries by Ownership

Physician Owned ASC 60.6%

Corporate Owned ASC 17.1%

Hospital Owned ASC 22.3%

Source MarketScope

9

Cataract Surgeons by Volume

200-59947.2%

600-119917.9% 1200-1599

2.6%

>16001.5%<100

13.3%100-19917.5%

Source MarketScope

10

What percentage of your eligible patients elected to receive premium IOLs in the past 3 months?

A. 0% to 10%B. 11% to 20%C. 21% to 30%D. Greater than 30%

Question #1

11

What premium lens is your lens of choice for your patients?

A. Crystalens 5.0B. Crystalens HDC. Crystalens AOD. Acrysof ReSTOR IOL (+3.0D)E. Tecnis MFF. AcrySof ToricG. OtherH. None, I prefer monofocal IOLs

Question #2

12

What is the most important distance to be on target for in the Premium Channel?

A. DistanceB. IntermediateC. Near

Question #3

13

If it was your own eye, which lens would you select?

A. AcrySof Toric IOLB. Tecnis Multifocal IOLC. Crystalens 5.0D. Crystalens HDE. Crystalens AOF. AcrySof ReSTOR IOL (+3.0)

Question #4